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This work aims to evaluate the potential of
1H Nuclear
Magnetic Resonance (NMR) spectroscopy combined
with multivariate statistics (metabonomics) for finding
malignancy biomarkers in lung tissue and discriminating
between different tumour histological types. Paired tis-
sue samples from 32 patients with primary lung cancer
were directly analysed by
1H High Resolution Magic
Angle Spinning (HRMAS) NMR (500 MHz) and the
spectral profiles subjected to Principal Component Ana-
lysis (PCA) and Partial Least Squares Regression Discri-
minant Analysis (PLS-DA). Tumor and control tissues
were clearly discriminated in the PLS-DA model with
95% sensitivity and 100% specificity. In agreement with
previous work [1], the metabolites giving rise to this
separation were mainly lactate, glycerophosphocholine,
phosphocholine, taurine, glutathione and uridine di/tri-
phosphate (elevated in tumours), and glucose, phos-
phoethanolamine, acetate, lysine, methionine, glycine,
myo-a n dscyllo-inositol (reduced in tumours compared
to control tissues). Regarding differentiation of histologi-
cal types, carcinoid tumors showed a distinct profile
characterized by very low lipid levels, the presence of
broad signals possibly arising from oligopeptides,
decreased PC/GPC ratio and increased taurine and
ascorbate levels. Epidermoid tumors could also be differ-
entiated from adenocarcinomas due to increased lipids,
lactate, creatine and GSH and decreased taurine, choline
and PC. The biochemical information retrieved, not
available by conventional histopathology, may provide
additional criteria for improving clinical decisions and
potentially aid in the differential diagnosis of lung
tumors.
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